Innoviva
INVA
#5381
Rank
S$2.04 B
Marketcap
S$27.64
Share price
1.13%
Change (1 day)
16.44%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): S$0.77 Billion

According to Innoviva's latest financial reports the company's current earnings are S$0.42 Billion. In 2025 the company made an earning of S$0.42 Billion, an increase over its 2024 earnings that were of S$48.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.77 B82.74%
2025 S$0.42 B774.24%
2024 S$48.2 M-80.74%
2023 S$0.25 B-32.36%
2022 S$0.36 B-35.56%
2021 S$0.57 B25.7%
2020 S$0.45 B52.11%
2019 S$0.30 B10.77%
2018 S$0.27 B56.59%
2017 S$0.17 B125.53%
2016 S$76.76 M-417.36%
2015 -S$24.19 Million-74.49%
2014 -S$94.81 Million-25.19%
2013 -S$0.13 Billion430.06%
2012 -S$23.91 Million-83.92%
2011 -S$0.15 Billion39.82%
2010 -S$0.11 Billion2.84%
2009 -S$0.11 Billion-8.62%
2008 -S$0.12 Billion-47.92%
2007 -S$0.22 Billion-5.92%
2006 -S$0.24 Billion19.8%
2005 -S$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.3 Billion-138.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.41 Million-103.03%๐Ÿ‡บ๐Ÿ‡ธ USA